Faculty of Health Sciences, University of Balamand, Beirut, Lebanon.
Department of Microbiology and Immunology, McGill University, Montréal, Québec, Canada.
Microbiol Spectr. 2024 Feb 6;12(2):e0312823. doi: 10.1128/spectrum.03128-23. Epub 2024 Jan 3.
Colonization with multidrug-resistant strains causes a substantial health burden in hospitalized patients. We performed a longitudinal genomics study to investigate the colonization of resistant strains in critically ill patients and to identify evolutionary changes and strain replacement events within patients. Patients were admitted to the intensive care unit and hematology wards at a major hospital in Lebanon. Perianal swabs were collected from participants on admission and during hospitalization, which were screened for extended-spectrum beta-lactamases and carbapenem-resistant Enterobacterales. We performed whole-genome sequencing and analysis on strains isolated from patients at multiple time points. The isolates were genetically diverse, with 11 sequence types (STs) identified among 22 isolates sequenced. Five patients were colonized by sequence type 131 (ST131)-encoding CTX-M-27, an emerging clone not previously observed in clinical samples from Lebanon. Among the eight patients whose resident strains were tracked over time, five harbored the same strain with relatively few mutations over the 5 to 10 days of hospitalization. The other three patients were colonized by different strains over time. Our study provides evidence of strain diversity within patients during their hospitalization. While strains varied in their antimicrobial resistance profiles, the number of resistance genes did not increase over time. We also show that ST131-encoding CTX-M-27, which appears to be emerging as a globally important multidrug-resistant strain, is also prevalent among critical care patients and deserves further monitoring.IMPORTANCEUnderstanding the evolution of bacteria over time in hospitalized patients is of utmost significance in the field of infectious diseases. While numerous studies have surveyed genetic diversity and resistance mechanisms in nosocomial infections, time series of within-patient dynamics are rare, and high-income countries are over-represented, leaving low- and middle-income countries understudied. Our study aims to bridge these research gaps by conducting a longitudinal survey of critically ill patients in Lebanon. This allowed us to track evolution and strain replacements within individual patients over extended periods. Through whole-genome sequencing, we found extensive strain diversity, including the first evidence of the emerging sequence type 131 clone encoding the CTX-M-27 beta-lactamase in a clinical sample from Lebanon, as well as likely strain replacement events during hospitalization.
耐多药 菌株的定植给住院患者带来了巨大的健康负担。我们进行了一项纵向基因组学研究,以调查重症患者中耐药 菌株的定植情况,并确定患者体内的进化变化和菌株替换事件。患者入住黎巴嫩一家大医院的重症监护病房和血液科病房。在入院时和住院期间,从参与者的肛周拭子中采集样本,筛选出具有广谱β-内酰胺酶和碳青霉烯类耐药肠杆菌科的样本。我们对来自多个时间点的患者的 菌株进行了全基因组测序和分析。这些 分离株的遗传多样性丰富,在 22 株测序的分离株中鉴定出 11 种序列型(ST)。5 名患者定植了携带 CTX-M-27 的 131 型(ST131),这是一种新出现的克隆,此前在黎巴嫩临床样本中未观察到。在 8 名其定植菌被跟踪的患者中,有 5 名在 5 至 10 天的住院期间携带相同的 菌株,突变相对较少。其他 3 名患者随着时间的推移被不同的 菌株定植。我们的研究提供了患者住院期间体内菌株多样性的证据。虽然菌株在其抗微生物药物耐药谱方面存在差异,但耐药基因的数量并没有随着时间的推移而增加。我们还表明,携带 CTX-M-27 的 ST131 似乎正在成为一种具有全球重要意义的多药耐药 菌株,在重症监护患者中也很常见,值得进一步监测。
了解住院患者体内细菌随时间的进化至关重要,因为这是传染病领域的关键问题。尽管有许多研究调查了医院感染中的遗传多样性和耐药机制,但很少有时间序列的患者内动态研究,而且高收入国家的研究较多,而低收入和中等收入国家的研究较少。我们的研究旨在通过对黎巴嫩重症患者进行纵向调查来填补这些研究空白。这使我们能够在较长时间内跟踪单个患者体内的 进化和菌株替换。通过全基因组测序,我们发现了广泛的菌株多样性,包括在黎巴嫩临床样本中首次发现携带 CTX-M-27 型β-内酰胺酶的新兴 131 型克隆的证据,以及住院期间可能发生的菌株替换事件。